Correlation Between Sartorius Stedim and Silver Bullet

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Silver Bullet at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Silver Bullet into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Silver Bullet Data, you can compare the effects of market volatilities on Sartorius Stedim and Silver Bullet and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Silver Bullet. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Silver Bullet.

Diversification Opportunities for Sartorius Stedim and Silver Bullet

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Sartorius and Silver is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Silver Bullet Data in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silver Bullet Data and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Silver Bullet. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silver Bullet Data has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Silver Bullet go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Silver Bullet

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to under-perform the Silver Bullet. But the stock apears to be less risky and, when comparing its historical volatility, Sartorius Stedim Biotech is 1.87 times less risky than Silver Bullet. The stock trades about -0.01 of its potential returns per unit of risk. The Silver Bullet Data is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  7,100  in Silver Bullet Data on October 13, 2024 and sell it today you would lose (850.00) from holding Silver Bullet Data or give up 11.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Silver Bullet Data

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Silver Bullet Data 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Silver Bullet Data are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Silver Bullet unveiled solid returns over the last few months and may actually be approaching a breakup point.

Sartorius Stedim and Silver Bullet Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Silver Bullet

The main advantage of trading using opposite Sartorius Stedim and Silver Bullet positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Silver Bullet can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silver Bullet will offset losses from the drop in Silver Bullet's long position.
The idea behind Sartorius Stedim Biotech and Silver Bullet Data pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine